|
ATP6V1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.961950E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.649950E-01 |
| Normal-vs-Stage2 |
3.634400E-01 |
| Normal-vs-Stage3 |
8.750100E-02 |
| Normal-vs-Stage4 |
1.279570E-01 |
| Stage1-vs-Stage2 |
1.381940E-02 |
| Stage1-vs-Stage3 |
4.875200E-01 |
| Stage1-vs-Stage4 |
5.410400E-01 |
| Stage2-vs-Stage3 |
9.842200E-03 |
| Stage2-vs-Stage4 |
2.594300E-02 |
| Stage3-vs-Stage4 |
9.386400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.939810E-02 |
| Normal-vs-AfricanAmerican |
3.160400E-01 |
| Normal-vs-Asian |
6.966800E-01 |
| Caucasian-vs-AfricanAmerican |
4.400100E-03 |
| Caucasian-vs-Asian |
7.144800E-03 |
| AfricanAmerican-vs-Asian |
5.295800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.958100E-02 |
| Normal-vs-Female |
3.654800E-01 |
| Male-vs-Female |
6.073700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.053400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.085200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.573200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.402170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.285600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.767600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.173900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.372800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.138100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.329500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.010800E-01 |
| Classical-VS-Follicular |
3.98209999996624E-06 |
| Classical-VS-Other |
3.176200E-01 |
| Classical-VS-Normal |
7.884700E-03 |
| Tall-VS-Follicular |
3.424900E-03 |
| Tall-VS-Other |
4.624800E-01 |
| Tall-VS-Normal |
2.026000E-01 |
| Follicular-VS-Other |
7.517400E-01 |
| Follicular-VS-Normal |
1.027640E-01 |
| Other-VS-Normal |
6.817800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.849200E-01 |
| Normal-vs-N1 |
4.960300E-03 |
| N0-vs-N1 |
1.474080E-02 |
|
|
